-transparent.png){kind=logo}
Vitamin E and percutaneous irradiation are the most common treatment regimens of Peyronie's disease. This report presents the results of 49 patients irradiated with 137Cs gamma rays. 28 of them had also received Vitamin E. An objective improvement was achieved in 37 patients (75%). Vitamin E did not show any additional benefit. In spite of the fact that these results do not permit an objective evaluation of both treatment regimens, the following advantages of radiotherapy should be considered: a) short treatment time b) low costs c) no serious side effects.
Related Publications
G Schmitt, and
G Kunitsch, and
P Rossbach, and
B Schreiber
January 1967,
Der Landarzt,
G Schmitt, and
G Kunitsch, and
P Rossbach, and
B Schreiber
June 1952,
Zeitschrift fur Haut- und Geschlechtskrankheiten,
G Schmitt, and
G Kunitsch, and
P Rossbach, and
B Schreiber
September 1980,
Deutsche medizinische Wochenschrift (1946),
G Schmitt, and
G Kunitsch, and
P Rossbach, and
B Schreiber
November 2003,
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
G Schmitt, and
G Kunitsch, and
P Rossbach, and
B Schreiber
May 1969,
Deutsche medizinische Wochenschrift (1946),
G Schmitt, and
G Kunitsch, and
P Rossbach, and
B Schreiber
September 1963,
Archivio per le scienze mediche,
G Schmitt, and
G Kunitsch, and
P Rossbach, and
B Schreiber
June 1998,
Therapeutische Umschau. Revue therapeutique,
G Schmitt, and
G Kunitsch, and
P Rossbach, and
B Schreiber
January 1969,
Dermatologische Monatschrift,
G Schmitt, and
G Kunitsch, and
P Rossbach, and
B Schreiber
February 1953,
Die Medizinische,
G Schmitt, and
G Kunitsch, and
P Rossbach, and
B Schreiber
September 1988,
Fortschritte der Medizin,
